Stimunity is a preclinical enterprise that focuses on creating top-notch medications targeting the STING pathway to activate the innate immune system. The company's treatments work to prompt the patient's immune system into action against infectious pathogens and cancer. The technology is derived from advanced academic research conducted at renowned institutions such as Institut Curie, the French National Institute of Health and Medical Research (Inserm), and University of Oxford.
Stimunity
Headquarters
France